In silico methods for predicting T-cell epitopes: Dr Jekyll or Mr Hyde?

References

• Fundamental Immunology. Paul WE (Ed.). Lippincott Williams and Wilkins, PA, USA (2003).
   Google Scholar
• Kaufmann SHE. The contribution of immunology to the rational design of novel antibacterial vaccines. Nat. Rev. Microbiol.5, 491–504 (2007).
   PubMed Web of Science ®Google Scholar
• Townsend ARM, Gotch FM, Davey J. Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell42, 457–467 (1985).
   PubMed Web of Science ®Google Scholar
• Sercarz EE, Lehmann PV, Ametani A et al. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol.11, 729–766 (1993).
   PubMed Web of Science ®Google Scholar
• Zinkernagel RM, Doherty PC. Restriction of in vitro T-cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature248, 701–702 (1974).
   PubMed Web of Science ®Google Scholar
• Davis MN, Flower DR. Harnessing bioinformatics to discover new vaccines. Drug Discov. Today12, 389–395 (2007).
   PubMedGoogle Scholar
• Robinson J, Waller MJ, Parham P et al. SGE IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucl. Acids Res.31, 311–314 (2003).
   PubMed Web of Science ®Google Scholar
• Babbitt B, Allen PM, Matsueda G et al. The binding of immunogenic peptides to Ia histocompatibility molecules. Nature317, 359–361 (1985).
   PubMed Web of Science ®Google Scholar
• Garrett TPJ, Saper MA, Bjorkman PJ et al. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature342, 692–696 (1989).
   PubMed Web of Science ®Google Scholar
• Reche PA, Glutting JP, Zhang H, Reinherz EL. Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics56, 405–419 (2004).
   PubMed Web of Science ®Google Scholar
• Tong JC, Tan TW, Ranganathan S. Methods and protocols for prediction of immunogenic epitopes. Brief Bioinformatics8, 96–108 (2006).
   PubMedGoogle Scholar
• Gowthaman U, Agrewala JN. In silico tools for predicting peptides binding to HLA-class II molecules: more confusion than conclusion. J. Proteome Res.7, 154–163 (2008).
   PubMed Web of Science ®Google Scholar
• Rothbard JB, Gefter ML. Interactions between immunogenic peptides and MHC proteins Annu. Rev. Immunol.9, 527–565 (1991).
   PubMed Web of Science ®Google Scholar
• Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Ann. Rev. Immunol.24, 419–466 (2006).
   PubMed Web of Science ®Google Scholar
• Baldi P, Brunak S, Chauvin Y et al. Assessing the accuracy of prediction algorithms for classification: an overview. Bioinformatics6(5), 412–424 (2000).
   Web of Science ®Google Scholar
• Greenbaum JA, Andersen PH, Blythe M et al. Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools. J. Mol. Recognit.20(2), 75–82 (2007).
   PubMed Web of Science ®Google Scholar
• Sette A, Buus S, Appella E et al. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc. Natl Acad. Sci. USA86, 3296–3300 (1989).
   PubMed Web of Science ®Google Scholar
• Rammensee H, Bachmann J, Emmerich NP et al. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics50, 213–219 (1999).
   PubMed Web of Science ®Google Scholar
• Kast WM, Brandt RM, Sidney J et al. Role of HLA-A motifs in identification of potential CTL epitopes in human papilloma virus type 16 E6 and E7 proteins. J. Immunol.152, 3904–3912 (1994).
   PubMed Web of Science ®Google Scholar
• Ruppert J, Sidney J, Celis E et al. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell74, 929–937 (1993).
   PubMed Web of Science ®Google Scholar
• Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol.152, 163–175 (1994).
   PubMed Web of Science ®Google Scholar
• Schönbach C, Ibe M, Shiga H et al. Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues. J. Immunol.14, 5951–5985 (1995).
   Google Scholar
• Southwood S, Sidney J, Kondo A et al. Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol.160, 3363–3373 (1998).
   PubMed Web of Science ®Google Scholar
• Nielsen M, Lundegaard C, Worning P et al. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics20, 1388–1397 (2004).
   PubMed Web of Science ®Google Scholar
• Rajapakse M, Wyse L, Schmidt B et al. Deriving matrix of peptide-MHC interactions in diabetic mouse by genetic algorithm. Lecture Notes in Computer Sci.3578, 440–447 (2005).
   Google Scholar
• Donnes P, Kohlbacher O. SVMHC: a server for prediction of MHC-binding peptides. Nucl. Acids Res.34(web server issue), W194–W197 (2006).
   PubMed Web of Science ®Google Scholar
• Brusic V, Rudy G, Honeyman G et al. Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics14, 121–130 (1998).
   PubMed Web of Science ®Google Scholar
• Yu K, Petrovsky N, Schönbach C et al. Methods for prediction of peptide binding to MHC molecules: a comparative study. Mol. Med.8, 137–148 (2002).
   PubMed Web of Science ®Google Scholar
• Mamitsuka H. Predicting peptides that bind to MHC molecules using supervised learning of hidden Markov models. Proteins33, 460–474 (1998).
   PubMed Web of Science ®Google Scholar
• Moutaftsi M, Peters B, Pasquetto V et al. A consensus epitope prediction approach identifies the breadth of murine T (CD8+)-cell responses to vaccinia virus. Nat. Biotechnol.24, 817–819 (2006).
   PubMed Web of Science ®Google Scholar
• Wen J-S, Jiang L-F, Zhou J-M et al. Computational prediction and identification of dengue virus-specific CD4+ T-cell epitopes. Virus Res.132, 42–48 (2008).
   PubMedGoogle Scholar
• Fonseca SG, Coutinho-Silva A, Fonseca LA et al. Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients. AIDS20, 2263–2273 (2006).
   PubMedGoogle Scholar
• Wang B, Yao K, Liu G, Xie F et al. Computational prediction and identification of Epstein–Barr virus latent membrane protein 2A antigen-specific CD8+ T-cell epitopes. Cell. Mol. Immunology.6(2), 97–103 (2009).
   PubMedGoogle Scholar
• Gritzapis AD, Voutsas IF, Lekka E et al. Identification of a novel immunogenic HLA-A*0201-binding epitope of HER-2/neu with potent antitumor properties. J. Immunol.181(1), 146–154 (2008).
   PubMedGoogle Scholar
• Shen L, Schroers R, Hammer J et al. Identification of a MHC class-II restricted epitope in carcinoembryonic antigen. Cancer Immunol. Immunother.53, 391–403 (2004).
   PubMedGoogle Scholar
• Campi G, Crosti M, Consogno G et al. CD4+ T cells from healthy subjects and colon cancer patients recognize a carcinoembryonic antigen-specific immunodominant epitope. Cancer Res.63, 8481–8486 (2003).
   PubMedGoogle Scholar
• Xing Q, Pang XW, Peng JR et al. Identification of new cytotoxic T-lymphocyte epitopes from cancer testis antigen HCA587. Biochem. Biophys. Res. Commun.372, 331–335 (2008).
   PubMedGoogle Scholar
• Asemissen AM, Keilholz U, Tenzer S et al. Identification of a highly immunogenic HLA-A*01-binding T cell epitope of WT1. Clin. Cancer Res.12, 7476–7482 (2006).
   PubMed Web of Science ®Google Scholar
• Schreurs MW, Kueter EW, Scholten KB et al. Identification of a potential human telomerase reverse transcriptase-derived, HLA-A1-restricted cytotoxic T-lymphocyte epitope. Cancer Immunol. Immunother.54, 703–712 (2005).
   PubMed Web of Science ®Google Scholar
• Maecker B, von Bergwelt-Baildon MS, Sherr DH et al. Identification of a new HLA-A*0201-restricted cryptic epitope from CYP1B1. Int. J. Cancer115, 333–336 (2005).
   PubMedGoogle Scholar
• Koren E, De Groot AS, Jawa V et al. Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein. Clin. Immunol.124, 26–32 (2007).
   PubMed Web of Science ®Google Scholar
• Carralot J, Dumrese C, Wessel R et al. CD8+ T cells specific for a potential HLA-A*0201 epitope from Chlamydophila pneumoniae are present in the PBMCs from infected patients. Int. Immunol.17, 591–597 (2005).
   PubMedGoogle Scholar
• Heidema J, de Bree GJ, De Graaff PM et al. Human CD8+ T cell responses against five newly identified respiratory syncytial virus-derived epitopes. J. Gen. Virol.85, 2365–2374 (2004).
   PubMed Web of Science ®Google Scholar
• Ouyang Q, Standifer NE, Qin H et al. Recognition of HLA class I-restricted β cell epitopes in Type 1 diabetes. Diabetes55, 3068–3074 (2006).
   PubMed Web of Science ®Google Scholar
• Standifer NE, Ouyang Q, Panagiotopoulos C et al. Identification of novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives. Diabetes55, 3061–3067 (2006).
   PubMed Web of Science ®Google Scholar
• Calvo-Calle JM, Strug I, Nastke MD et al. Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection. PLoS Pathog.3, E144 (2007).
   Google Scholar
• Larsen MV, Lundegaard C, Lamberth K et al. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics8, 424 (2007).
   PubMed Web of Science ®Google Scholar
• Gomez-Nunez M, Pinilla-Ibarz J, Dao T et al. Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A*0201 molecules. Leukemia Res.30, 1293–1298 (2006).
   PubMedGoogle Scholar
• Al-Attiyah R, Mustafa AS. Computer-assisted prediction of HLA-DR binding and experimental analysis for human promiscuous Th1-cell peptides in the 24 kDa secreted lipoprotein (LppX) of Mycobacterium tuberculosis. Scand. J. Immunol.59, 16–24 (2004).
   PubMed Web of Science ®Google Scholar
• Stober CB, Lange UG, Roberts MT et al. From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine leishmania major infection. Vaccine24, 2602–2616 (2006).
   PubMed Web of Science ®Google Scholar
• Drouin EE, Glickstein L, Kwok WW et al. Searching for borrelial T cell epitopes associated with antibiotic-refractory Lyme arthritis. Mol. Immunol.45, 2323–2332 (2008).
   PubMedGoogle Scholar
• Nyárády Z, Czömpöly T, Bosze S et al. Validation of in silico prediction by in vitro immunoserological results of fine epitope mapping on citrate synthase specific autoantibodies. Mol. Immunol.43, 830–838 (2006).
   PubMed Web of Science ®Google Scholar
• Andersen MH, Tan L, Søndergaard I et al. Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules. Tissue Antigens55, 519–31 (2000).
   PubMedGoogle Scholar
• Pelte C, Cherepnev G, Wang Y et al. Random screening of proteins for HLA-A*0201-binding nine-amino acid peptides is not sufficient for identifying CD8 T cell epitopes recognized in the context of HLA-A*0201. J. Immunol.172, 6783–6789 (2004).
   PubMed Web of Science ®Google Scholar
• Neumann F, Wagner C, Stevanovic S et al. Identification of an HLA-DR-restricted peptide epitope with a promiscuous binding pattern derived from the cancer testis antigen HOM-MEL-40/SSX2. Int. J. Cancer112, 661–668 (2004).
   PubMedGoogle Scholar
• Mustafa AS, Shaban FA. ProPred analysis and experimental evaluation of promiscuous T-cell epitopes of three major secreted antigens of Mycobacterium tuberculosis. Tuberculosis86, 115–124 (2006).
   PubMed Web of Science ®Google Scholar
• Crowe SR, Miller SC, Brown DM et al. Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine24, 457–467 (2006).
   PubMed Web of Science ®Google Scholar
• Lee S, Miller SA, Wright DW et al. Tissue-specific regulation of CD8-T-lymphocyte immunodominance in respiratory syncytial virus infection. J. Virol.81, 2349–2358 (2007).
   PubMed Web of Science ®Google Scholar
• Trost B, Bickis M, Kusalik A. Strength in numbers: achieving greater accuracy in MHC-I binding prediction by combining the results from multiple prediction tools. Immunome Res.3, 5 (2007).
   PubMedGoogle Scholar
• Doolan DL, Southwood S, Freilich DA et al. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc. Natl Acad. Sci. USA100, 9952–9957 (2003).
   PubMed Web of Science ®Google Scholar
• Lin HH, Zhang GL, Tongchusak S et al. Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. BMC Bioinformatics12(9 Suppl. 12), S22 (2008).
   Google Scholar
• Hennecke J, Wiley DC. T cell receptor-MHC interactions up close. Cell104, 1–4 (2001).
   PubMed Web of Science ®Google Scholar
• Stern LJ, Brown JH, Jardetzky TS et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature368, 215–221 (1994).
   PubMed Web of Science ®Google Scholar
• Sturniolo T, Bono E, Ding J et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol.17, 555–561 (1999).
   PubMed Web of Science ®Google Scholar
• El-Manzalawy Y, Dobbs D, Honavar V. On evaluating MHC-II binding peptide prediction methods. PLoS ONE24, 3(9) E3268 (2008).
   Google Scholar
• Suri A, Lovitch SB, Unanue ER. The wide diversity and complexity of peptides bound to class II MHC molecules. Curr. Opin. Immunol.18(1), 70–77 (2006).
   PubMedGoogle Scholar
• Lin HH, Ray S, Tongchusak S et al. Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMC Immunol.9, 8 (2008).
   PubMed Web of Science ®Google Scholar
• MacNamara A, Kadolsky U, Bangham CRM, Asquith B. T-cell epitope prediction: rescaling can mask biological variation between MHC molecules. PLoS Comput. Biol.5(3), E1000327 (2009).
   Google Scholar
• Agrewala JN, Wilkinson RJ. Influence of HLA-DR on the phenotype of CD4+ T lymphocytes specific for an epitope of the 16-kDa α-crystallin antigen of Mycobacterium tuberculosi. Eur. J. Immunol.29, 1753–1761 (1999).
   PubMed Web of Science ®Google Scholar
• Agrewala JN, Wilkinson RJ. Differential regulation of Th1 and Th2 cells by p91–110 and p21–40 peptides of the 16-kD α-crystallin antigen of Mycobacterium tuberculosis. Clin. Exp. Immunol.114(3), 392–397 (1998).
   PubMed Web of Science ®Google Scholar
• Halling-Brown M, Sansom CE, Davies M et al. Are bacterial vaccine antigens T-cell epitope depleted? Trends Immunol.29(8), 374–379 (2008).
   PubMed Web of Science ®Google Scholar